The editors welcome Dr. Elli Theel to the editorial board of the *Clinical Microbiology Newsletter*. Dr. Theel is currently the Director of the Infectious Diseases Serology laboratory and Co-Director of the Vector-borne Diseases Service Line at Mayo Clinic in Rochester, Minnesota. She is also an Associate Professor of Laboratory Medicine and Pathology and is the Microbiology and Public Health CPEP Fellowship Program Director at Mayo Clinic. In 2010, Dr. Theel received her Ph.D. in Medical Microbiology and Immunology from the University of Wisconsin-Madison. She then completed her fellowship in Medical and Public Health Microbiology at Mayo Clinic and is board-certified by the American Board of Medical Microbiology (ABMM).

Dr. Theel's clinical research interests revolve around developing and evaluating antibody and antigen detection assays for a variety of different infectious disease pathogens. In particular, she has focused on optimizing specific and pan-fungal antigen detection assays, assessing novel methods for serodiagnosis of Lyme disease and developing antibody index assays for more accurate diagnosis of neuroinvasive infections, including, most notably, for neuroinvasive Lyme disease \[[@bib1], [@bib2], [@bib3], [@bib4]\]. Dr. Theel also leads the Integrated Mayo Program for Arthropod-borne diseases Community education, Teaching and Surveillance (IMPACTS) Initiative, a benefactor-funded project located in Belize, Central America. The initiative is a multi-institution collaboration between Mayo Clinic and the University of Notre Dame, with the overarching goals to enhance in-country clinical laboratory quality assurance practices, increasing testing capacity, establishing arthropod-borne seroprevalence rates in the country, and providing public health education regarding vector-borne diseases. Most recently, Dr. Theel has been heavily involved in the development and evaluation of emerging serologic tests for detection of antibodies to SARS-CoV-2, and has focused on providing education and guidance to clinicians, the public, and government officials on appropriate utilization and interpretation of results from these tests \[[@bib5], [@bib6]; <https://asm.org/Articles/Policy/2020/May/Coronavirus-Webinar-Series-The-Microbial-Sciences>\].
